Cocrystal Pharma (COCP) Treasury Shares (2014 - 2026)
Cocrystal Pharma (COCP) posted Treasury Shares of $221000.0 for Q1 2026, up 127.84% sequentially from $97000.0 in Q4 2025, and up 42.58% YoY from $155000.0 in Q1 2025.
Cocrystal Pharma (COCP) Treasury Shares (2014 - 2026) Analysis & Trends
Cocrystal Pharma has reported Treasury Shares for 9 years, with the latest figure at $221000.0 in Q1 2026.
- Quarterly Treasury Shares rose 42.58% year-over-year to $221000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $221000.0 (up 42.58% YoY) and the FY2025 annual result came in at $97000.0, down 62.11% from the prior year.
- Treasury Shares rose to $221000.0 in Q1 2026 per COCP's latest filing, from $97000.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $256000.0 in Q4 2024 and troughed at $97000.0 in Q4 2025.
- A 3-year average of $165857.1 and a median of $155000.0 in 2025 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2025 and 2026: Treasury Shares sank 62.11% in 2025, then surged 42.58% in 2026.
- Over 3 years, Treasury Shares stood at $256000.0 in 2024, then tumbled by 62.11% to $97000.0 in 2025, then jumped by 127.84% to $221000.0 in 2026.
- According to Business Quant data, Treasury Shares over the past three periods registered $221000.0, $97000.0, and $113000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Cocrystal Pharma | 15.65 Mn | 13.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 219,000.00 |
| Jun 30, 2026 | 219,000.00 |
| Mar 31, 2026 | 221,000.00 |
| Mar 31, 2026 | 221,000.00 |
| Dec 31, 2025 | 97,000.00 |
| Dec 31, 2025 | 97,000.00 |
| Sep 30, 2025 | 113,000.00 |
| Sep 30, 2025 | 113,000.00 |
| Jun 30, 2025 | 155,000.00 |
| Jun 30, 2025 | 155,000.00 |
| Mar 31, 2025 | 155,000.00 |
| Mar 31, 2025 | 155,000.00 |
| Dec 31, 2024 | 256,000.00 |
| Dec 31, 2024 | 256,000.00 |
| Sep 30, 2024 | 164,000.00 |
| Sep 30, 2024 | 164,000.00 |
| Mar 31, 2019 | 133,000.00 |
| Mar 31, 2019 | 133,000.00 |
| Dec 31, 2018 | 243,000.00 |
| Dec 31, 2018 | 243,000.00 |